BioMarker Strategies Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Debt - PPP
- Investors
-
4
BioMarker Strategies General Information
Description
Developer of tissue-based cancer diagnostics system designed to offer predictive tests to guide targeted drug development and treatment selection for patients. The company's system offers a live tumor cell testing device to guide targeted drug development and treatment selection for patients with solid tumor malignancies, enabling cancer patients to treat tumor malignancies with personalized medicine.
Contact Information
Website
www.biomarkerstrategies.comCorporate Office
- 15601 Crabbs Branch Way
- Derwood
- Rockville, MD 20855
- United States
Corporate Office
- 15601 Crabbs Branch Way
- Derwood
- Rockville, MD 20855
- United States
BioMarker Strategies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Debt - PPP | 03-May-2020 | Completed | Generating Revenue | |||
| 14. Grant | 16-Sep-2019 | Completed | Generating Revenue | |||
| 13. Later Stage VC | 06-Sep-2016 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 02-Dec-2013 | Completed | Generating Revenue | |||
| 11. Grant | 25-Sep-2013 | Completed | Generating Revenue | |||
| 10. Grant | 28-Sep-2011 | Completed | Generating Revenue | |||
| 9. Early Stage VC | 28-Sep-2011 | Completed | Generating Revenue | |||
| 8. Seed Round | 15-Nov-2010 | Completed | Generating Revenue | |||
| 7. Grant | 04-May-2010 | $1M | $1.46M | Completed | Generating Revenue | |
| 6. Angel (individual) | 16-Feb-2010 | $273K | $1.46M | Completed | Generating Revenue |
BioMarker Strategies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BioMarker Strategies Patents
BioMarker Strategies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220339257-A1 | Methods to increase the sensitivity and reversing the resistance to drugs | Pending | 18-Sep-2019 | ||
| US-20220347267-A1 | Methods to improve patient response to immune checkpoint inhibitors and functional tests to predict response | Pending | 18-Sep-2019 | ||
| AU-2020348365-A1 | Methods to improve patient response to immune checkpoint inhibitors and functional tests to predict response | Inactive | 18-Sep-2019 | ||
| EP-4031181-A2 | Methods to improve patient response to immune checkpoint inhibitors and functional tests to predict response | Inactive | 18-Sep-2019 | ||
| CA-3148971-A1 | Methods to improve patient response to immune checkpoint inhibitors and functional tests to predict response | Inactive | 18-Sep-2019 | A61K38/19 |
BioMarker Strategies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BioMarker Strategies Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| TEDCO | Venture Capital | Minority | ||
| Abell Foundation | Not-For-Profit Venture Capital | |||
| National Cancer Institute | Government | |||
| Springboard Enterprises | Accelerator/Incubator | Minority |
BioMarker Strategies FAQs
-
When was BioMarker Strategies founded?
BioMarker Strategies was founded in 2007.
-
Where is BioMarker Strategies headquartered?
BioMarker Strategies is headquartered in Rockville, MD.
-
What is the size of BioMarker Strategies?
BioMarker Strategies has 8 total employees.
-
What industry is BioMarker Strategies in?
BioMarker Strategies’s primary industry is Diagnostic Equipment.
-
Is BioMarker Strategies a private or public company?
BioMarker Strategies is a Private company.
-
What is BioMarker Strategies’s current revenue?
The current revenue for BioMarker Strategies is .
-
How much funding has BioMarker Strategies raised over time?
BioMarker Strategies has raised $7.95M.
-
Who are BioMarker Strategies’s investors?
TEDCO, Abell Foundation, National Cancer Institute, and Springboard Enterprises have invested in BioMarker Strategies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
